309 related articles for article (PubMed ID: 17018637)
21. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
22. Obesity and risk of non-Hodgkin lymphoma (United States).
Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD
Cancer Causes Control; 2007 Aug; 18(6):677-85. PubMed ID: 17484069
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
[TBL] [Abstract][Full Text] [Related]
24. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
25. The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk.
Cozen W; Cerhan JR; Martinez-Maza O; Ward MH; Linet M; Colt JS; Davis S; Severson RK; Hartge P; Bernstein L
Cancer Causes Control; 2007 Oct; 18(8):821-31. PubMed ID: 17588155
[TBL] [Abstract][Full Text] [Related]
26. Association between a polymorphism in the lymphotoxin-a promoter region and migraine.
Lee KA; Jang SY; Sohn KM; Won HH; Kim MJ; Kim JW; Chung CS
Headache; 2007; 47(7):1056-62. PubMed ID: 17635597
[TBL] [Abstract][Full Text] [Related]
27. Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.
Xiong XD; Qiu FE; Fang JH; Shen Y; Liang C; Jiang W; Zhuang SM
Mutat Res; 2009 Mar; 662(1-2):10-5. PubMed ID: 19101572
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes.
Monroy CM; Cortes AC; Lopez MS; D'Amelio AM; Etzel CJ; Younes A; Strom SS; El-Zein RA
Mol Carcinog; 2011 Jan; 50(1):36-46. PubMed ID: 21061265
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
Rothman N; Skibola CF; Wang SS; Morgan G; Lan Q; Smith MT; Spinelli JJ; Willett E; De Sanjose S; Cocco P; Berndt SI; Brennan P; Brooks-Wilson A; Wacholder S; Becker N; Hartge P; Zheng T; Roman E; Holly EA; Boffetta P; Armstrong B; Cozen W; Linet M; Bosch FX; Ennas MG; Holford TR; Gallagher RP; Rollinson S; Bracci PM; Cerhan JR; Whitby D; Moore PS; Leaderer B; Lai A; Spink C; Davis S; Bosch R; Scarpa A; Zhang Y; Severson RK; Yeager M; Chanock S; Nieters A
Lancet Oncol; 2006 Jan; 7(1):27-38. PubMed ID: 16389181
[TBL] [Abstract][Full Text] [Related]
31. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the Fc gamma receptor IIA.
Kim YS; Yoo JH; Lee BC
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):353-7. PubMed ID: 19357503
[TBL] [Abstract][Full Text] [Related]
33. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
[TBL] [Abstract][Full Text] [Related]
34. [The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas].
Kalinka E; Juszczyński P; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffier B; Salles G; Warzocha K
Przegl Lek; 2005; 62(12):1422-6. PubMed ID: 16786764
[TBL] [Abstract][Full Text] [Related]
35. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
[TBL] [Abstract][Full Text] [Related]
36. Atopy and risk of non-Hodgkin lymphoma.
Melbye M; Smedby KE; Lehtinen T; Rostgaard K; Glimelius B; Munksgaard L; Schöllkopf C; Sundström C; Chang ET; Koskela P; Adami HO; Hjalgrim H
J Natl Cancer Inst; 2007 Jan; 99(2):158-66. PubMed ID: 17227999
[TBL] [Abstract][Full Text] [Related]
37. Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample.
Zhao ZZ; Nyholt DR; Le L; Thomas S; Engwerda C; Randall L; Treloar SA; Montgomery GW
Hum Reprod; 2007 Sep; 22(9):2389-97. PubMed ID: 17595314
[TBL] [Abstract][Full Text] [Related]
38. Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma.
Piras G; Monne M; Uras A; Palmas A; Murineddu M; Arru L; Bianchi A; Calvisi A; Curreli L; Gaviano E; Lai P; Murgia A; Latte GC; Noli A; Gabbas A
Br J Haematol; 2005 Jun; 129(6):784-90. PubMed ID: 15953005
[TBL] [Abstract][Full Text] [Related]
39. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
[TBL] [Abstract][Full Text] [Related]
40. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
